Home » Topics » Regulatory

Regulatory
RSS

Boehringer Ingelheim seeks approval for combination hypertension treatments

Feb. 8, 2000

Levaquin as the first antimicrobial for CAP caused by resistant S. pneumoniae

Feb. 7, 2000

Restenosis prevention trial of tranilast is largest ever

Feb. 7, 2000

COX-2 inhibitor now available for FAP indication

Feb. 4, 2000

Sporanox Injection now available for treatment of serious fungal infections

Feb. 4, 2000

IND filed for nasal leuprolide as endometriosis therapy

Feb. 3, 2000

NDA filed for once-daily didanosine capsules

Feb. 2, 2000

FDA advisory committee recommends approval of Novantrone for MS indication

Feb. 1, 2000

Access to begin phase II trial of OraRinse for treatment and prevention of mucositis

Jan. 31, 2000

Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer

Jan. 28, 2000

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...